Iván Chivite

465 total citations
18 papers, 102 citations indexed

About

Iván Chivite is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Iván Chivite has authored 18 papers receiving a total of 102 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 8 papers in Virology and 8 papers in Epidemiology. Recurrent topics in Iván Chivite's work include HIV/AIDS Research and Interventions (12 papers), HIV Research and Treatment (8 papers) and HIV/AIDS drug development and treatment (7 papers). Iván Chivite is often cited by papers focused on HIV/AIDS Research and Interventions (12 papers), HIV Research and Treatment (8 papers) and HIV/AIDS drug development and treatment (7 papers). Iván Chivite collaborates with scholars based in Spain, United States and United Kingdom. Iván Chivite's co-authors include Montserrat Laguno, Juan Ambrosioni, Lorena de la Mora, Estebán Martínez, Elisa de Lazzari, Alexy Inciarte, Berta Torres, Maria Martínez‐Rebollar, Josep Mallolas and Ana González-Cordón and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy and Medicine.

In The Last Decade

Iván Chivite

14 papers receiving 99 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Iván Chivite Spain	5	94	57	37	26	8	18	102
Ainoa Ugarte Spain	6	86 0.9×	58 1.0×	36 1.0×	29 1.1×	6 0.8×	21	117
Penh Sun Ly Vietnam	8	103 1.1×	57 1.0×	36 1.0×	43 1.7×	5 0.6×	21	123
Supunnee Jirajariyavej Thailand	8	139 1.5×	110 1.9×	35 0.9×	41 1.6×	9 1.1×	13	184
Aimee Freeman United States	7	82 0.9×	21 0.4×	18 0.5×	44 1.7×	5 0.6×	12	109
Oon Tek Ng Singapore	8	106 1.1×	42 0.7×	39 1.1×	68 2.6×	6 0.8×	15	136
Anna Vassilenko Belarus	5	101 1.1×	45 0.8×	35 0.9×	55 2.1×	3 0.4×	11	142
Agnes Kiragga Uganda	6	159 1.7×	93 1.6×	26 0.7×	42 1.6×	7 0.9×	10	175
Warangkana Munsakul Thailand	8	154 1.6×	118 2.1×	48 1.3×	16 0.6×	4 0.5×	15	171
Junine Toy Canada	6	140 1.5×	95 1.7×	14 0.4×	50 1.9×	5 0.6×	20	164
Tebogo Segolodi United States	5	101 1.1×	39 0.7×	29 0.8×	62 2.4×	17 2.1×	7	131

Countries citing papers authored by Iván Chivite

Since Specialization

Citations

This map shows the geographic impact of Iván Chivite's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Iván Chivite with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Iván Chivite more than expected).

Fields of papers citing papers by Iván Chivite

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Iván Chivite. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Iván Chivite. The network helps show where Iván Chivite may publish in the future.

Co-authorship network of co-authors of Iván Chivite

This figure shows the co-authorship network connecting the top 25 collaborators of Iván Chivite. A scholar is included among the top collaborators of Iván Chivite based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Iván Chivite. Iván Chivite is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Vergara, Andrea, Iván Chivite, Ana González-Cordón, et al.. (2025). Detection of Neisseria gonorrhoeae and Chlamydia trachomatis by PCR in a sample pool (urine, rectum and pharynx) in asymptomatic patients at risk of sexually transmitted infections. Enfermedades Infecciosas y Microbiología Clínica. 43(7). 374–377.

Alonso, Rodrigo, Iván Chivite, Lorena de la Mora, et al.. (2025). The Role of Protease Inhibitors in HIV Treatment: Who Still Needs Them in 2025?. Infectious Diseases and Therapy. 14(11). 2551–2563.

Laguno, Montserrat, Elisa de Lazzari, Alexy Inciarte, et al.. (2024). Burden of liver steatosis and liver fibrosis in a large cohort of people living with HIV. HIV Medicine. 25(12). 1308–1324. 1 indexed citations

Chivite, Iván, Elisa de Lazzari, Soodabeh Navadeh, et al.. (2024). Effectiveness, safety and discontinuation rates of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) in people with HIV using real-world data: a systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy. 79(8). 1775–1783. 9 indexed citations

Ugarte, Ainoa, Lorena de la Mora, Elisa de Lazzari, et al.. (2024). Rapid initiation of bictegravir/emtricitabine/tenofovir alafenamide as first-line therapy in HIV infection. A prospective study. Journal of Antimicrobial Chemotherapy. 79(9). 2343–2353. 1 indexed citations

Palacio‐Vieira, Jorge, Yesika Díaz, Jordi Aceitón, et al.. (2023). Who is lost to follow‐up in HIV care? Assessment of care retention over time and the impact of COVID‐19. Longitudinal analysis of the PISCIS cohort. HIV Medicine. 24(9). 965–978. 4 indexed citations

González-Cordón, Ana, Alexy Inciarte, Lorena de la Mora, et al.. (2023). Sex-based epidemiological and immunovirological characteristics of people living with HIV in current follow-up at a tertiary hospital: a comparative retrospective study, Catalonia, Spain, 1982 to 2020. Eurosurveillance. 28(10).

Lazzari, Elisa de, Montserrat Laguno, Iván Chivite, et al.. (2023). Perception of quality of care using patient reported experience measures (PREMs) in a cohort of adults with HIV: A cross-sectional study. Medicine. 102(14). e33442–e33442.

Lazzari, Elisa de, Lorena de la Mora, Alexy Inciarte, et al.. (2023). Clinical use and effectiveness of dolutegravir and lamivudine: a long-term, real-world, retrospective study. Journal of Antimicrobial Chemotherapy. 78(8). 1955–1962. 4 indexed citations

10.

Mora, Lorena de la, Ainoa Ugarte, Maria Martínez‐Rebollar, et al.. (2022). Chemsex Practices in PrEP: Beyond Addiction and Risk Toward a Healthy Sex Life—Baseline Experiences from a Hospital-Based PrEP Program in Barcelona, Spain. AIDS and Behavior. 26(12). 4055–4062. 10 indexed citations

11.

Mora, Lorena de la, Maria Martínez‐Rebollar, Elisa de Lazzari, et al.. (2022). Do ART and Chemsex Drugs Get Along? Potential Drug–Drug Interactions in a Cohort of People Living with HIV Who Engaged in Chemsex: A Retrospective Observational Study. Infectious Diseases and Therapy. 11(6). 2111–2124. 8 indexed citations

12.

Ugarte, Ainoa, Lorena de la Mora, Maria Martínez‐Rebollar, et al.. (2022). Evolution of Risk Behaviors, Sexually Transmitted Infections and PrEP Care Continuum in a Hospital-Based PrEP Program in Barcelona, Spain: A Descriptive Study of the First 2 Years’ Experience. Infectious Diseases and Therapy. 12(2). 425–442. 3 indexed citations

13.

Chivite, Iván, Josep Riera‐Monroig, Juan Ambrosioni, & Montserrat Laguno. (2022). HIV infection in the setting of PrEP: Development of antiretroviral resistance and breakthrough infection. Report of two cases in real-life. Enfermedades infecciosas y microbiologia clinica (English ed ). 40(5). 280–281. 2 indexed citations

14.

Fuertes, Irene, Iván Chivite, Ross Cranston, et al.. (2022). Short-term effectiveness and tolerability of carbon dioxide laser for anal high-grade squamous intraepithelial lesions in individuals living with HIV. International Journal of STD & AIDS. 33(7). 709–717. 1 indexed citations

15.

Laguno, Montserrat, Ainoa Ugarte, Maria Martínez‐Rebollar, et al.. (2021). Experiencia de un programa de profilaxis preexposición en una unidad de virus de la inmunodeficiencia humana hospitalaria. Descripción del perfil basal del usuario e identificación de oportunidades de mejora. Enfermedades Infecciosas y Microbiología Clínica. 41(1). 24–28. 2 indexed citations

16.

Ambrosioni, Juan, Alexy Inciarte, Lorena de la Mora, et al.. (2021). Real-life experience with bictegravir/emtricitabine/tenofovir alafenamide in a large reference clinical centre. Journal of Antimicrobial Chemotherapy. 77(4). 1133–1139. 41 indexed citations

17.

Chivite, Iván, Josep Riera‐Monroig, Juan Ambrosioni, & Montserrat Laguno. (2021). HIV infection in the setting of PrEP: Development of antiretroviral resistance and breakthrough infection. Report of two cases in real-life. Enfermedades Infecciosas y Microbiología Clínica. 40(5). 280–281. 2 indexed citations

18.

Imaz, Arkaitz, Juan Tiraboschi, Jordí Niubó, et al.. (2020). Dynamics of the Decay of Human Immunodeficiency Virus (HIV) RNA and Distribution of Bictegravir in the Genital Tract and Rectum in Antiretroviral-naive Adults Living With HIV–1 Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (Spanish HIV/AIDS Research Network, PreEC/RIS 58). Clinical Infectious Diseases. 73(7). e1991–e1999. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact